UBS O'Connor’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
14,510
+3,590
| +33% | +$281K | 0.06% | 181 |
|
|
2025
Q1 | $791K | Buy |
10,920
+1,160
| +12% | +$84.1K | 0.02% | 189 |
|
|
2024
Q4 | $723K | Buy |
9,760
+2,760
| +39% | +$204K | 0.02% | 249 |
|
|
2024
Q3 | $462K | Buy |
+7,000
| New | +$462K | 0.01% | 335 |
|
|
2016
Q2 | – | Sell |
-15,000
| Closed | -$441K | – | 390 |
|
|
2016
Q1 | $441K | Buy |
+15,000
| New | +$441K | 0.01% | 352 |
|
|
2015
Q3 | – | Sell |
-14,904
| Closed | -$354K | – | 537 |
|
|
2015
Q2 | $354K | Buy |
14,904
+2,430
| +19% | +$57.7K | 0.01% | 626 |
|
|
2015
Q1 | $296K | Buy |
+12,474
| New | +$296K | 0.01% | 609 |
|